Risk of Thrombocytopenia by SSRIs or SNRIs in Patients With Depression Based on MID‐NET: A Cohort Study in Japan

Risk of Thrombocytopenia by SSRIs or SNRIs in Patients With Depression Based on MID‐NET: A Cohort Study in Japan

ABSTRACT Risk assessment on thrombocytopenia by selective serotonin reuptake inhibitors (SSRIs) or serotonin noradrenaline reuptake inhibitors (SNRIs) is limited. An observational study with cohort design was conducted based on the MID‐NET for evaluating the risk of thrombocytopenia by SSRIs and SNR...

Full description

Saved in:
Bibliographic Details
Main Authors: Yusuke Okada, Kazuhiro Kajiyama, Maki Komamine, Takashi Ando, Tomoaki Hasegawa, Chieko Ishiguro, Takahiro Nonaka, Mariko Tsukuda, Yukari Iwasaki, Takahiro Ueda, Naoya Horiuchi, Toyotaka Iguchi, Yoshiaki Uyama
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Clinical and Translational Science
Subjects:
depression
drug safety
pharmacoepidemiology
thrombocytopenia
Online Access:https://doi.org/10.1111/cts.70268
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1111/cts.70268

Similar Items